1998
DOI: 10.1097/00005392-199812010-00136
|View full text |Cite
|
Sign up to set email alerts
|

Botulinum A Toxin Treatment for Detrusor-Sphincter Dyssynergia in Spinal Cord Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
19
0
2

Year Published

2004
2004
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(22 citation statements)
references
References 1 publication
1
19
0
2
Order By: Relevance
“…Studies comparing the success of sphincterotomy, either as an irreversible surgical procedure or as a reversible treatment with botulinum toxin A injection [9] or placement of urethral stents [10] , have used variable outcome criteria. Reduction of residual urine has frequently been used for this purpose.…”
Section: Discussionmentioning
confidence: 99%
“…Studies comparing the success of sphincterotomy, either as an irreversible surgical procedure or as a reversible treatment with botulinum toxin A injection [9] or placement of urethral stents [10] , have used variable outcome criteria. Reduction of residual urine has frequently been used for this purpose.…”
Section: Discussionmentioning
confidence: 99%
“…Thus, botulinum-A toxin has been used to treat neurogenic detrusor overactivity, DSD, and motosensory urge. When the toxin is injected transurethrally or transperineally, it deceases EUS amplitude, voiding pressure, and postvoid residual volume (106,272). In 2000, botulinum-A toxin was first used to treat neurogenic bladder hyperactivity in spinal cord injured patients by injection into the bladder detrusor (303).…”
Section: Detrusor-sphincter Dyssynergiamentioning
confidence: 99%
“…The dyssynergia is abolished for a few months, necessitating repeat injections. The efficacy of this treatment is high and there are few adverse effects (148)(149)(150).…”
Section: 36mentioning
confidence: 99%